The researchers investigated the association between histopathologic characteristics, such as inflammation, in sinus tissue of patients with chronic rhinosinusitis and levels of air pollution and ozone...
In order to increase awareness of chronic upper airway diseases, which affect over 30% of the world’s population, the European Academy of Allergy and Clinical Immunology (EAACI) has developed the Global...
Stapokibart, a novel anti–IL-4Rα monoclonal antibody, significantly reduced nasal polyp size and congestion in patients with severe chronic rhinosinusitis with nasal polyps, with improvements evident as...
